ATE229953T1 - Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems - Google Patents

Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems

Info

Publication number
ATE229953T1
ATE229953T1 AT98950904T AT98950904T ATE229953T1 AT E229953 T1 ATE229953 T1 AT E229953T1 AT 98950904 T AT98950904 T AT 98950904T AT 98950904 T AT98950904 T AT 98950904T AT E229953 T1 ATE229953 T1 AT E229953T1
Authority
AT
Austria
Prior art keywords
treatment
nervous system
central nervous
disorders
naphtho
Prior art date
Application number
AT98950904T
Other languages
English (en)
Inventor
Allen B Reitz
James J Mcnally
Pauline Sanfilippo
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE229953T1 publication Critical patent/ATE229953T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT98950904T 1997-10-07 1998-10-05 Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems ATE229953T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6123497P 1997-10-07 1997-10-07
PCT/US1998/020865 WO1999018104A1 (en) 1997-10-07 1998-10-05 Naphtho-imidazo[1,2-a]pyridine derivatives, their preparation and their use in treating central nervous system disorders

Publications (1)

Publication Number Publication Date
ATE229953T1 true ATE229953T1 (de) 2003-01-15

Family

ID=22034502

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98950904T ATE229953T1 (de) 1997-10-07 1998-10-05 Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems

Country Status (11)

Country Link
US (1) US6200984B1 (de)
EP (1) EP1025101B1 (de)
JP (1) JP2001519350A (de)
AT (1) ATE229953T1 (de)
AU (1) AU737177B2 (de)
CA (1) CA2305348A1 (de)
DE (1) DE69810340T2 (de)
DK (1) DK1025101T3 (de)
ES (1) ES2190112T3 (de)
PT (1) PT1025101E (de)
WO (1) WO1999018104A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008696D0 (en) 2000-04-07 2000-05-31 Merck Sharp & Dohme Therapeutic agents
EP1567497B1 (de) * 2002-12-06 2009-09-23 Purdue Research Foundation Pyridine zur behandlung von verletztemsäugetiernervengewebe
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
US7678474B2 (en) * 2005-07-22 2010-03-16 Lg Chem. Ltd. Imidazole derivatives and organic electronic device using the same
EP2472911A1 (de) 2010-12-29 2012-07-04 British Telecommunications Public Limited Company Proximitätsdienst für WLAN-Vorrichtung
EP2469945A1 (de) 2010-12-23 2012-06-27 British Telecommunications public limited company WLAN-Lokalisierungsdienste

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0656002B1 (de) * 1992-08-19 2000-11-08 Mcneilab, Inc. 3-oxo-pyrido [1,2-a] benzimidazol-4-carboxyl und 4-oxo-azepino [1,2-a] benzimidazol-5-carboxyl derivate geeignet für die behandlung von zentralnervensystemerkrankungen
PT935598E (pt) * 1996-10-07 2004-03-31 Ortho Mcneil Pharm Inc Derivados de 3-oxo-pirido (1,2-a)benzimidazole-4-carboxamida alquilo substituidos contendo 5 heteroatomos uteis no tratamento de disturbios do sistema nervoso central

Also Published As

Publication number Publication date
EP1025101A1 (de) 2000-08-09
DE69810340T2 (de) 2003-10-30
US6200984B1 (en) 2001-03-13
EP1025101B1 (de) 2002-12-18
CA2305348A1 (en) 1999-04-15
WO1999018104A1 (en) 1999-04-15
DE69810340D1 (de) 2003-01-30
AU9682798A (en) 1999-04-27
ES2190112T3 (es) 2003-07-16
JP2001519350A (ja) 2001-10-23
AU737177B2 (en) 2001-08-09
PT1025101E (pt) 2003-04-30
DK1025101T3 (da) 2003-04-07

Similar Documents

Publication Publication Date Title
CA2258548A1 (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
BG101715A (bg) Тетрациклени спиросъединения,метод за тяхното получаване и приложението им като 5нт долу 1d рецепторни антагонисти
UA66825C2 (uk) Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності
IS1904B (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
MY107157A (en) Quinuclidine derivatives.
CA2134964A1 (en) Bridged Aza-Bicyclic Derivatives as Substance P Antagonists
MY128659A (en) Novel aminodicarboxylic acid derivatives having pharmaceutical properties
YU45403A (sh) Novi 1,2-difenil-azetidinoni, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena za lečenje poremećaja u metabolizmu lipida
GEP20022676B (en) 4-Phenyl-Pyridine Derivatives, Method for Their Production and Their Use for Treatment of Disorders Caused by Antagonist of NK-1 Receptors
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
AP9701041A0 (en) Pyridylpyrrole compounds.
ATE223912T1 (de) Pyridylalkan-säureamide als cytostatika und immunosupressive arzneimittel
RU94042907A (ru) Производные имидазопиридина, способ их получения, фармацевтическая композиция и способ ее получения
CA2094703A1 (en) Substituted piperazines as central nervous system agents
ATE247645T1 (de) Neue piperazinylalkylthiopyrimidine derivate, diese enthaltende pharmazeutische zusammenstellungen und verfahren zu deren herstellung
HK1046404A1 (zh) 用作nmda受体拮抗剂的取代的吡咯烷-2，3，4-三酮-3-肟衍生物
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
ATE229953T1 (de) Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems
UA41329C2 (uk) Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, похідні 3-фенілсульфоніл-3,7-діазабіцикло[3,3,1]нонану та лікарський засіб для лікування аритмії
ATE417831T1 (de) Ceramid ähnliche verbindungen, verfahren zu deren herstellung und deren verwendung als antitumormittel
YU19302A (sh) 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
ATE209633T1 (de) Pyridinderivate,als arzneimittel zur behandlung von geschwüren und als antibakterielle mittel
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
HUT71127A (en) 2,3,4,5-tetrahydro-1h-3-benzodiazepines and pharmaceutically acceptable acid additional salts thereof, pharmaceutical compositions containing them and process for their preparation
HUT44515A (en) Process for producing isoquinolinol compounds of heart activity increasing, phosphodiesterase iii inhibiting and/or renal vasodilating activity and pharmaceutical composition containing them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1025101

Country of ref document: EP

REN Ceased due to non-payment of the annual fee